🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

LIVE NOW | From RWE to RCTs and Beyond: Evidence and Advancements in the Field of #PulmonaryEmbolism Treatment with Peter Monteleone, MD, FACC, FSCAI, Sahil A. Parikh, MD, Greg Piazza, MD, Mahesh Raju, MD, and DR MICHAEL R JAFF #TheVEINS24 The VEINS Meeting

ROADSTER 3 30-day outcomes are in: TCAR delivers the lowest stroke rates in the first-ever independently adjudicated study for standard surgical risk patients. Learn More about the ROADSTER 3 Clinical Data: silkroadmed.com/healthcare-pro… Learn More about TCAR: silkroadmed.com/healthcare-pro…

What a great turnout! Thank you to the fellows/residents who attended “Morning Pulse: Navigating the Future as a NextGen Leader in #VascularHealth" this morning at #VIVA24. Big thanks to our distinguished panelists for their great guidance and discussion. The VIVA Foundation

Presented at #VIVA24 | #ELEGANCE Registry data show #Eluvia and #Ranger deliver excellent clinical outcomes in females & underrepresented racial/ethnic populations despite these patients presenting with more advanced disease. #evidencebasedmedicine #healthequity #diversity

🗓️Join us next week to discuss The "Usual" Intermediate-High Risk PE Case…And "What Else” - The Usual: Standard PE case - What Else: Case with PFO present - What Else: Case with very short duration, low dose lytic protocol Register Today: qrco.de/ViEWebinar

In the #REALPE Analysis, the in-hospital mortality rates for #EKOS and FlowTriever were found to be comparable. Learn more about real-world evidence and BSC’s dedication to enhancing care for #pulmonaryembolism: bit.ly/4fNLPIJ #WhyWeEKOS

We’re excited to add TCAR technology to Boston Scientific’s portfolio. CAD is a rapidly growing therapy area affecting nearly half a million new patients annually in the US. As one company, we’re excited to bring this therapy to more patients. *Available only in US currently

Continue following Silk Road Medical’s journey, now as a part of #BostonScientific, by following Jeff Mirviss and Cat Jennings. #ForwardTogether #ENROUTE

Big news! Upon close and regulatory approval, we look forward to providing physicians and their patients access to this emerging, high-growth therapy for treatment of complex cardiovascular diseases.

Reserve your seat for this semi-annual, 2-day educational event focused on #PAD and #VTE, featuring a multidisciplinary expert faculty panel🗓️ #MedEd Pre-register now: qrco.de/AVMC

❤️ Proudly wearing red today along with many of my colleagues on Boston Scientific's Vascular team to raise awareness for women’s heart health! Heart disease is the No. 1 killer of women, claiming one life every minute. #GoRedBSC #WomensHealth Jeff Mirviss Boston Scientific

Join us at #VENOUS2025 to hear expert faculty, Keith Sterling, Juan Carlos Jimenez MD, MBA, Misaki Kiguchi, MD, and Mikel Sadek, MD discuss #Varithena's versatility, effectiveness & unique patent benefits through clinical case presentations & panel discussion. American Venous Forum | AVF

Congratulations! 👏 #ENROUTE Jeff Mirviss

Join us for an enlightening discussion as thought leaders spanning diverse medical specialties share the latest clinical data & their perspectives on the future of #PE. PERT Consortium Keith Sterling Daniella KadianDodov Peter Monteleone, MD, FACC, FSCAI #MedEd Register now: bit.ly/42Uy0o7

Last weekend, physicians from across the U.S. attended our #AdvancedVascularMasterClass to explore emerging vascular tech, share insights & engage in dynamic breakout sessions and discussions. Big thanks to our expert faculty & attendees for a successful event! #MedEd

Join us at #VS2025 as we dive into real-world venous cases where anatomy, reflux, and technology shape complexity. Discover how #Varithena can simplify even the most unexpected scenarios. Not all cases are what they seem—let’s explore why. #VenousCare #VenousSymposium

Don’t miss our upcoming webinar: "Simply Complicated or Complicatedly Simple?" Join expert faculty and esteemed moderators for an engaging session on interventions for #DVT, featuring #SmartClaw case discussions. 📅Register now: bit.ly/4jUv3tT

🗓️ Join us at #NCVH2025 for a live case featuring an expert operator and panel who will discuss the application of #Ranger200cm to treat complex lesions and evidence-based decision making with #drugeluting therapies. #DCB #DrugCoatedBalloon #PAD